Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU
- 1 March 1985
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 14 (2), 156-159
- https://doi.org/10.1007/bf00434356
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitroCancer Chemotherapy and Pharmacology, 1983
- Stem cell studies of human malignant brain tumorsJournal of Neurosurgery, 1983
- A Critical Appraisal of the Human Tumor Stem-Cell AssayNew England Journal of Medicine, 1983
- (2-Chloroethyl)nitrosourea congeners of amino acid amidesJournal of Medicinal Chemistry, 1982
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980
- Cytotoxicity as an indicator for transport mechanism. Evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cellBiochimica et Biophysica Acta (BBA) - Biomembranes, 1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Primary Bioassay of Human Myeloma Stem CellsJournal of Clinical Investigation, 1977
- Human bone marrow colony growth in agar‐gelJournal of Cellular Physiology, 1970
- Some Special Kinetic Problems of TransportPublished by Wiley ,1969